Ent Sinus
Payments companies reported to CMS as associated with Ent Sinus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ent Sinus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ent Sinus
These are the largest totals companies reported as associated with Ent Sinus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joshua Greene | Anderson, IN | Otolaryngology | $16,661.36 |
| Kelvin Kwong | New Brunswick, NJ | Pediatric Otolaryngology | $15,623.21 |
| Zorik Spektor | Boynton Beach, FL | Pediatric Otolaryngology | $15,062.50 |
| Jordan Schramm | Provo, UT | Pediatric Otolaryngology | $15,016.36 |
| Ryan Walker | Cherry Hill, NJ | Pediatric Otolaryngology | $10,500.00 |
| Jonathan Walsh | Baltimore, MD | Pediatric Otolaryngology | $7,125.00 |
| Stephen Maturo | Portland, ME | Otolaryngology | $6,037.50 |
| Philip Ryan Camilon | Danvers, MA | Pediatric Otolaryngology | $4,875.00 |
| Jane Dillon | Ormond Beach, FL | Otolaryngology | $800.00 |
| Priyesh Patel | Nashville, TN | Otolaryngology | $246.12 |
Prescribed Ent Sinus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.